Skip to Content


In the US, Requip (ropinirole systemic) is a member of the drug class dopaminergic antiparkinsonism agents and is used to treat Parkinson's Disease, Periodic Limb Movement Disorder and Restless Legs Syndrome.

US matches:

UK matches:

Ingredient matches for Requip


Ropinirole is reported as an ingredient of Requip in the following countries:

  • Bosnia & Herzegowina
  • Serbia
  • South Africa
  • Tunisia
  • Turkey

Ropinirole hydrochloride (a derivative of Ropinirole) is reported as an ingredient of Requip in the following countries:

  • Argentina
  • Belgium
  • Canada
  • China
  • Czech Republic
  • France
  • Hong Kong
  • Ireland
  • Italy
  • Japan
  • Lithuania
  • Malta
  • Netherlands
  • New Zealand
  • Oman
  • Poland
  • Slovakia
  • Spain
  • Sweden
  • Taiwan
  • United Kingdom
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.